Cambridge Cognition Holdings PLC
F:1M7

Watchlist Manager
Cambridge Cognition Holdings PLC Logo
Cambridge Cognition Holdings PLC
F:1M7
Watchlist
Price: 0.392 EUR -0.51%
Market Cap: €16.4m

Operating Margin

-12.7%
Current
Declining
by 1.2%
vs 3-y average of -11.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-12.7%
=
Operating Income
£-1.2m
/
Revenue
£9.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-12.7%
=
Operating Income
€-1.2m
/
Revenue
£9.1m

Peer Comparison

Country Company Market Cap Operating
Margin
UK
Cambridge Cognition Holdings PLC
LSE:COG
18.4m GBP
Loading...
US
Cerner Corp
LSE:0R00
31.3B USD
Loading...
US
Veeva Systems Inc
NYSE:VEEV
28.3B USD
Loading...
AU
Pro Medicus Ltd
ASX:PME
13B AUD
Loading...
JP
M3 Inc
TSE:2413
1.1T JPY
Loading...
US
Waystar Holding Corp
NASDAQ:WAY
4.6B USD
Loading...
SE
Sectra AB
STO:SECT B
43.6B SEK
Loading...
US
Doximity Inc
NYSE:DOCS
4.2B USD
Loading...
US
Vocera Communications Inc
F:V00
2.4B EUR
Loading...
CN
Winning Health Technology Group Co Ltd
SZSE:300253
18.9B CNY
Loading...
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
228.4B INR
Loading...

Market Distribution

Lower than 95% of companies in United Kingdom
Percentile
5th
Based on 3 579 companies
5th percentile
-12.7%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

Cambridge Cognition Holdings PLC
Glance View

Market Cap
16.4m EUR
Industry
Health Care

Cambridge Cognition Holdings Plc is a neuroscience digital health company, which engages in the development of digital health products to better understand, detect, and treat conditions affecting brain health. The firm develops and markets digital solutions to assess brain health for sale worldwide, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight and NeuroVocalix. Its services include neuroscience consultancy, study design, data analysis, study management, data management plan, reporting and interpretation and technical consultancy. Its CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas. Its Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone applications for high frequency data collection to demonstrate treatment efficacy and increase the understanding of a disease and a patient's response to medication.

1M7 Intrinsic Value
0.932 EUR
Undervaluation 58%
Intrinsic Value
Price €0.392
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-12.7%
=
Operating Income
£-1.2m
/
Revenue
£9.1m
What is Cambridge Cognition Holdings PLC's current Operating Margin?

The current Operating Margin for Cambridge Cognition Holdings PLC is -12.7%, which is below its 3-year median of -11.5%.

How has Operating Margin changed over time?

Over the last 3 years, Cambridge Cognition Holdings PLC’s Operating Margin has decreased from 1.7% to -12.7%. During this period, it reached a low of -20.6% on Jun 30, 2023 and a high of 1.7% on Jun 30, 2022.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett